Importance of Hollow or Solid Centralizer for Polished, Collarless and Tapered Stems in Total Hip Arthroplasty

November 25, 2014 updated by: Region Skane

Comparing Hollow and Solid Centralizer Designs When Using a Polished, Collarless, Tapered Hip Prosthesis Stem (MS30). A Prospective, Randomized, Multicenter Study Evaluated by RadioStereometric Analysis (RSA).

The study aims at comparing the effect of hollow or solid centralizer designs on the long time fixation behaviour of hip prosthesis stems that are polished, tapered and collarless. In a prospective, controlled and randomized study comprising two groups of 30 patients/hips each, the patients will be followed up by RadioStereometric Analysis (RSA) for ten years. In completion general health questionnaires as well as hip specific scoring instruments will be used to evaluate patient satisfaction and outcome.The hypothesis of the study is that the different centralizers will result in different migration patterns of the stems, which might affect the risk for late aseptic loosening.

Study Overview

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Skåne
      • Lund, Skåne, Sweden, 221 85
        • Department of Orthopedics, Skåne University Hospital, Lund University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Primary osteoarthritis of the hip necessitating primary hip replacement
  • Charnley classification group A and B
  • Age 60 - 85 years old at the inclusion time of the study.

Exclusion Criteria:

  • Secondary osteoarthritis
  • Rheumatoid arthritis
  • Malignant disease
  • Severe osteoporosis
  • Earlier fracture or operation in the hip to be operated on
  • Peroperative fracture
  • Ongoing corticosteroid (oral) or immunosuppressive medication
  • Personal disorders (dementia, alcohol or drug abuse etc) suspected of making completion of the trial uncertain.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Hollow Centralizer
The stem used (MS30)was originally designed with a solid centralizer but has been redesigned to be used with a hollow centralizer.
The stem used (MS30)was originally designed with a solid centralizer but has been redesigned to be used with a hollow centralizer. The patients are randomized to either solid or hollow centralizer
This is the stem used in the study.
Active Comparator: Solid Centralizer
The stem used (MS30)was originally designed with a solid centralizer but has been redesigned to be used with a hollow centralizer.
This is the stem used in the study.
The stem used (MS30)was originally designed with a solid centralizer but has been redesigned to be used with a hollow centralizer. The patients are randomized to either solid or hollow centralizer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiostereometric Analysis (RSA)
Time Frame: The first postoperative day, 6 months, 1, 2, 5 and 10 years
This will measure the change in stem migration over time and be indicative of long term result.
The first postoperative day, 6 months, 1, 2, 5 and 10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
x-ray
Time Frame: The first postoperative day, 6 months, 1, 2, 5 and 10 years
On standard x-rays the progress of radiolucent lines or other signs of loosening will be measured
The first postoperative day, 6 months, 1, 2, 5 and 10 years
Hip specific questionnaire
Time Frame: Preoperatively, 1, 2, 5 and 10 years
Hip disability and Osteoarthritis Score (HOOS) - this is a hip specific questionnaire that will measure how the operation has affected the patients hip function and pain situation
Preoperatively, 1, 2, 5 and 10 years
General health questionnaire
Time Frame: Preoperatively, 1, 2, 5 and 10 years
EuroQol (EQ-5D) - a standardized instrument for use as measure of general health outcome
Preoperatively, 1, 2, 5 and 10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2003

Primary Completion (Actual)

February 1, 2004

Study Completion (Actual)

November 1, 2014

Study Registration Dates

First Submitted

July 4, 2013

First Submitted That Met QC Criteria

August 5, 2013

First Posted (Estimate)

August 7, 2013

Study Record Updates

Last Update Posted (Estimate)

November 26, 2014

Last Update Submitted That Met QC Criteria

November 25, 2014

Last Verified

November 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • Centralizer study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Hip Arthroplasty

Clinical Trials on Hollow Centralizer

3
Subscribe